Clinical Application of Sequential Epigenetic Analysis for Diagnosis of Silver–Russell Syndrome

키워드

참고문헌 (33)

1. Silver HK, "Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotropins", Pediatrics, 12, pp.368~376 (1953)
2. Russell A, "A syndrome of intra-uterine dwarfism recognizable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies (5 examples)", Proc R Soc Med, 47, pp.1040~1044 (1954)
3. Wollmann HA, "Growth and symptoms in Silver–Russell syndrome: review on the basis of 386 patients", Eur J Pediatr, 154, pp.958~968 (1995)
4. Eggermann T, "Russell–Silver syndrome", Am J Med Genet C Semin Med Genet, 154C, pp.355~364 (2010)
5. Gicquel C, "Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver–Russell syndrome", Nat Genet, 37, pp.1003~1007 (2005)
6. Eggermann T, "Epigenetic mutations in 11p15 in Silver–Russell syndrome are restricted to the telomeric imprinting domain", J Med Genet, 43, pp.615~616 (2006)
7. Netchine I, "11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell–Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations", J Clin Endocrinol Metab, 92, pp.3148~3154 (2007)
8. Kotzot D, "Uniparental disomy 7 in Silver–Russell syndrome and primordial growth retardation", Hum Mol Genet, 4, pp.583~587 (1995)
9. Abu-Amero S, "The genetic aetiology of Silver–Russell syndrome", J Med Genet, 45, pp.193~199 (2008)
10. Cytrynbaum C, "Genomic imbalance in the centromeric 11p15 imprinting center in three families: Further evidence of a role for IC2 as a cause of Russell-Silver syndrome", Am J Med Genet A, 170, pp.2731~2739 (2016)
11. Inoue T, "Genetic heterogeneity of patients with suspected Silver–Russell syndrome: genome-wide copy number analysis in 82 patients without imprinting defects", Clin Epigenetics, 9, pp.52~ (2017)
12. Crippa M, "Molecular etiology disclosed by array CGH in patients with Silver–Russell syndrome or similar phenotypes", Front Genet, 10, pp.955~ (2019)
13. Brioude F, "CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell–Silver syndrome", J Med Genet, 50, pp.823~830 (2013)
14. Begemann M, "Paternally inherited IGF2 mutation and growth restriction", N Engl J Med, 373, pp.349~356 (2015)
15. Abi Habib W, "Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction", Genet Med, 20, pp.250~258 (2018)
16. Luk HM, "Silver–Russell syndrome in a patient with somatic mosaicism for upd(11)mat identified by buccal cell analysis", Am J Med Genet A, 170, pp.1938~1941 (2016)
17. Eggermann T, "Silver–Russell syndrome: genetic basis and molecular genetic testing", Orphanet J Rare Dis, 5, pp.19~ (2010)
18. Price SM, "The spectrum of Silver–Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria", J Med Genet, 36, pp.837~842 (1999)
19. Hitchins MP, "Silver–Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions", J Med Genet, 38, pp.810~819 (2001)
20. Azzi S, "A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver–Russell syndrome", J Med Genet, 52, pp.446~453 (2015)
21. Luk HM, "Silver-Russell syndrome in Hong Kong", Hong Kong Med J, 22, pp.526~533 (2016)
22. Wakeling EL, "Diagnosis and management of Silver–Russell syndrome: first international consensus statement", Nat Rev Endocrinol, 13, pp.105~124 (2017)
23. 김재현, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects", Clinical and Experimental Pediatrics, 61(5), pp.135~149 (2018), 대한소아청소년과학회
24. Lee BH, "Quantitative analysis of methylation status at 11p15 and 7q21 for the genetic diagnosis of Beckwith–Wiedemann syndrome and Silver–Russell syndrome", J Hum Genet, 58, pp.604~610 (2013)
25. Fuke T, "Molecular and clinical studies in 138 Japanese patients with Silver–Russell syndrome", PLoS One, 8, pp.e60105~ (2013)
26. Russo S, "A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver–Russell and Beckwith-Wiedemann syndromes", Clin Epigenetics, 8, pp.23~ (2016)
27. Wakeling EL, "Epigenotype-phenotype correlations in Silver–Russell syndrome", J Med Genet, 47, pp.760~768 (2010)
28. 장우리, "Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay", Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea, 2019, pp.39(3), 299~310[DOI]
29. 이진숙, "Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability", Annals of Laboratory Medicine, 38(5), pp.473~480 (2018), 대한진단검사의학회[DOI]
30. Chernausek SD, "Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: the National Cooperative Growth study experience", J Pediatr, 128, pp.S22~S27 (1996)
31. Toumba M, "Effect of long-term growth hormone treatment on final height of children with Russell–Silver syndrome", Horm Res Paediatr, 74, pp.212~217 (2010)
32. Binder G, "Adult height and epigenotype in children with Silver–Russell syndrome treated with GH", Horm Res Paediatr, 80, pp.193~200 (2013)
33. Rakover Y, "Growth hormone therapy in Silver–Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW)", Eur J Pediatr, 155, pp.851~857 (1996)

관련 논문AI추천